Most Likely Diagnosis: Solitary Plasmacytoma
For an asymptomatic adult patient with normal blood workups and a solitary lytic lesion in the inferior right occipital bone, the most likely diagnosis is solitary plasmacytoma of bone. 1, 2, 3
Diagnostic Reasoning
Why Plasmacytoma is Most Likely
Solitary plasmacytoma characteristically presents as a lytic skull lesion in asymptomatic patients with normal laboratory studies, distinguishing it from multiple myeloma which requires end-organ damage (hypercalcemia, renal failure, anemia, or multiple lytic lesions). 4, 1
The occipital bone location is a recognized site for solitary plasmacytoma, with documented cases presenting as painless, solitary lytic lesions in otherwise asymptomatic patients. 5, 3
Normal blood workups effectively exclude symptomatic multiple myeloma, which requires either serum M-protein ≥3 g/dL and/or bone marrow plasma cells ≥10% plus clinical manifestations (anemia, hypercalcemia, renal failure, or multiple lytic lesions). 4
Key Distinguishing Features from Multiple Myeloma
A single asymptomatic lytic bone lesion with normal labs does NOT meet criteria for symptomatic multiple myeloma, which requires evidence of end-organ damage attributable to plasma cell disorder. 4
The International Myeloma Working Group specifically notes that in patients with a single asymptomatic lytic bone lesion, benign conditions including bone cysts or angiomas should be considered, and advanced imaging (CT or MRI) is helpful for differential diagnosis. 4
Patients with apparent solitary plasmacytoma who have bone marrow plasmacytosis >10% are reclassified as having multiple myeloma, but this requires bone marrow biopsy for confirmation. 2
Alternative Diagnoses to Consider (Less Likely Given Clinical Context)
Giant cell tumor of bone can present as an expansile lytic occipital lesion in young adults (typically ages 20-40), but these are usually symptomatic with localized tenderness and palpable swelling. 6
Metastatic disease is less likely in a truly asymptomatic patient with normal blood workups and no known primary malignancy, though breast, lung, renal, and thyroid cancers characteristically produce lytic skull metastases. 7
Ewing's sarcoma typically presents in children and adolescents with systemic symptoms (intermittent high fever) and local pain, making it unlikely in an asymptomatic adult. 8
Intraosseous meningioma is rare and usually exhibits osteoblastic (not purely lytic) activity, though purely lytic variants have been documented. 9
Mandatory Next Steps for Definitive Diagnosis
Immediate Imaging Requirements
Obtain MRI with gadolinium contrast immediately to assess bone marrow involvement, soft tissue extension, and intracranial complications—this is the gold standard for skull base lesions. 1, 2
Perform CT with bone windows concurrently to evaluate cortical bone detail and identify the precise extent of osseous destruction. 1, 2
Complete whole-body low-dose CT (WBLD-CT) to exclude additional lytic lesions that would indicate multiple myeloma rather than solitary plasmacytoma (Grade 1A recommendation). 1, 2
Essential Laboratory Workup
Serum protein electrophoresis with immunofixation to detect monoclonal protein. 1, 2
Serum free light chain assay to identify abnormal kappa/lambda ratios. 1, 2
Complete blood count, serum calcium, creatinine, and albumin to exclude end-organ damage from multiple myeloma. 2
Tissue Diagnosis (Mandatory Before Treatment)
Unilateral bone marrow aspiration and trephine biopsy with flow cytometry is mandatory to detect occult bone marrow involvement—flow cytometry detects occult disease in 49-68% of apparent solitary plasmacytoma cases, and these patients have dramatically higher progression rates to multiple myeloma (71-72% versus 8-12.5%). 2
Image-guided biopsy of the occipital lesion (CT-guided) is essential for definitive histologic diagnosis before treatment planning. 1
Critical Pitfalls to Avoid
Do not assume this is benign without excluding plasma cell neoplasms and metastatic disease through appropriate laboratory and imaging studies—solitary lytic skull lesions require systematic exclusion of malignancy. 1
Do not rely solely on normal blood workups to exclude plasmacytoma—up to 30% of solitary plasmacytomas have no detectable serum M-protein, and bone marrow evaluation with flow cytometry is mandatory. 2
Do not skip bone marrow biopsy—occult marrow involvement detected by flow cytometry dramatically changes prognosis and treatment approach, converting apparent solitary plasmacytoma to multiple myeloma. 2
Do not perform any surgical intervention until malignancy is excluded—this can complicate definitive surgical management if the lesion proves malignant. 1